ES2180702T3 - Tratamiento de patologias por la induccion del factor de transcripcion bef-1. - Google Patents
Tratamiento de patologias por la induccion del factor de transcripcion bef-1.Info
- Publication number
- ES2180702T3 ES2180702T3 ES96303876T ES96303876T ES2180702T3 ES 2180702 T3 ES2180702 T3 ES 2180702T3 ES 96303876 T ES96303876 T ES 96303876T ES 96303876 T ES96303876 T ES 96303876T ES 2180702 T3 ES2180702 T3 ES 2180702T3
- Authority
- ES
- Spain
- Prior art keywords
- bef
- transcription factor
- pathologies
- induction
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
UN METODO PARA INDUCIR EL FACTOR DE TRANSCRIPCION BEF-1 QUE CONSISTE EN ADMINISTRAR A UNA PERSONA QUE LO NECESITE UNA CANTIDAD EFICAZ DE UN COMPUESTO CON LA FORMULA DONDE R{SUP,1} Y R{SUP,3} SON, INDEPENDIENTEMENTE, HIDROGENO, CH{SUB,3}, -C=O-(C{SUB,1}-C{SUB,6} ALQUIL) O -C=O-AR, DONDE AR ES UN FENILO OPCIONALMENTE SUSTITUIDO; R{SUP,2} SE SELECCIONA DE UN GRUPO FORMADO POR PIRROLIDINA, HEXAMETILENAMINO Y PIPERIDINO O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE ESTOS COMPUESTOS SOLVATADOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47949895A | 1995-06-07 | 1995-06-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2180702T3 true ES2180702T3 (es) | 2003-02-16 |
Family
ID=23904277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES96303876T Expired - Lifetime ES2180702T3 (es) | 1995-06-07 | 1996-05-30 | Tratamiento de patologias por la induccion del factor de transcripcion bef-1. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0747051B1 (es) |
JP (1) | JPH11506771A (es) |
AU (1) | AU6040296A (es) |
BR (1) | BR9609053A (es) |
CA (1) | CA2223175A1 (es) |
DE (1) | DE69622472T2 (es) |
ES (1) | ES2180702T3 (es) |
WO (1) | WO1996040130A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5990129A (en) * | 1997-09-23 | 1999-11-23 | Eli Lilly And Company | Methods for regulating trkA expression |
WO2006045010A2 (en) * | 2004-10-20 | 2006-04-27 | Resverlogix Corp. | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
EP2314295B1 (en) | 2005-07-29 | 2015-01-28 | Resverlogix, Inc | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
PL2118074T3 (pl) | 2007-02-01 | 2014-06-30 | Resverlogix Corp | Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego |
CN101970416B (zh) | 2008-06-26 | 2014-05-28 | 雷斯韦洛吉克斯公司 | 制备喹唑啉酮衍生物的方法 |
NZ594332A (en) | 2009-01-08 | 2013-09-27 | Resverlogix Corp | Compounds for the prevention and treatment of cardiovascular disease |
AU2010224523B2 (en) | 2009-03-18 | 2014-05-08 | Resverlogix Corp. | Novel anti-inflammatory agents |
LT2421533T (lt) | 2009-04-22 | 2018-12-27 | Resverlogix Corp. | Nauji priešuždegiminiai agentai |
US9610251B2 (en) | 2011-11-01 | 2017-04-04 | Resverlogix Corp. | Pharmaceutical compositions for substituted quinazolinones |
WO2014080290A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Cyclic amines as bromodomain inhibitors |
WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
CN105073744B (zh) | 2012-12-21 | 2019-11-08 | 齐尼思表观遗传学有限公司 | 作为溴结构域抑制剂的新型杂环化合物 |
US10111885B2 (en) | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
US5441965A (en) * | 1993-12-21 | 1995-08-15 | Eli Lilly And Company | Methods of inhibiting thrombin |
US5492927A (en) * | 1993-12-21 | 1996-02-20 | Eli Lilly And Company | Non-peptide tachykinin receptor antagonists to treat allergy |
US5476862A (en) * | 1993-12-21 | 1995-12-19 | Eli Lilly And Company | Methods of increasing thrombomodulin expression |
AU698389B2 (en) * | 1993-12-21 | 1998-10-29 | Eli Lilly And Company | Methods for inhibiting LDL oxidation and atheroclerosis |
US5545641A (en) * | 1994-10-20 | 1996-08-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of bradykinin |
-
1996
- 1996-05-30 ES ES96303876T patent/ES2180702T3/es not_active Expired - Lifetime
- 1996-05-30 EP EP96303876A patent/EP0747051B1/en not_active Expired - Lifetime
- 1996-05-30 DE DE69622472T patent/DE69622472T2/de not_active Expired - Fee Related
- 1996-06-05 AU AU60402/96A patent/AU6040296A/en not_active Abandoned
- 1996-06-05 WO PCT/US1996/008752 patent/WO1996040130A1/en active Application Filing
- 1996-06-05 BR BR9609053A patent/BR9609053A/pt not_active Application Discontinuation
- 1996-06-05 CA CA002223175A patent/CA2223175A1/en not_active Abandoned
- 1996-06-05 JP JP9501249A patent/JPH11506771A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0747051A3 (en) | 1997-02-26 |
BR9609053A (pt) | 1999-01-26 |
AU6040296A (en) | 1996-12-30 |
EP0747051B1 (en) | 2002-07-24 |
CA2223175A1 (en) | 1996-12-19 |
EP0747051A2 (en) | 1996-12-11 |
JPH11506771A (ja) | 1999-06-15 |
DE69622472T2 (de) | 2003-02-06 |
DE69622472D1 (de) | 2002-08-29 |
WO1996040130A1 (en) | 1996-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2180702T3 (es) | Tratamiento de patologias por la induccion del factor de transcripcion bef-1. | |
EA199700117A1 (ru) | Трициклические бензазепиновые антагонисты вазопрессина, способ их получения, фармацевтическая композиция и способ лечения млекопитающих с использованием трициклических бензазепинов | |
ES2153851T3 (es) | Tratamiento de la atrofia de la piel y de la vagina. | |
ES2102154T3 (es) | Inhibicion de trombina. | |
FI20011100A (fi) | Menetelmä terapeuttisesti käyttökelpoisten trisyklisten bentsatsepiinien valmistamiseksi | |
ATE196140T1 (de) | Substituierte benzylaminoquinuclidine als substanz p antagonisten | |
ES2175336T3 (es) | Derivados de triazol utiles en terapia. | |
ES2193142T3 (es) | Uso de benzotiofenos para el tratamiento de hipercolesterolemia. | |
EA200801805A1 (ru) | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения | |
EA199700111A1 (ru) | Трициклические бензазепиновые антагонисты вазопрессина | |
ES2122456T3 (es) | Aminoacidos excitadores sinteticos. | |
UY24935A1 (es) | Antagonistas del receptor de vitronectina | |
ATE25682T1 (de) | Indol-3-carboxamid-derivate. | |
KR910016915A (ko) | 과콜레스테롤혈증 치료제 | |
DE69431035D1 (de) | 2-Phenyl-3-Azoylbenzothiophene zur Erhöhung der Thrombomodulin Expression | |
ES2195089T3 (es) | Benzotiofenos amorfos, procedimientos de preparacion y uso. | |
ES2178382T3 (es) | Compuestos de benciloxiprodigiosina. | |
HU913891D0 (en) | Method for producing new phenyl-alkyl-amino-alkyl derivatives and medical preparatives containing said compounds | |
DK0404055T3 (da) | Antimetastatisk virksomt stof fra den sydamerikanske igle Haementeria ghilianii | |
SE9400810D0 (sv) | New use of Quinoline-3-carboxamide compounds | |
ES2195313T3 (es) | Derivados de imino-aza-antraciclinona para el tratamiento de la amiloidosis. | |
RU98123606A (ru) | Способ лечения псориаза | |
ES2052730T3 (es) | Mejoras en o relativas a antagonistas de leucotrienos. | |
DE50211559D1 (en) | Hydrophilieadditive | |
KR940005541A (ko) | 치환된 벤조에이트 유도체 |